Long-read sequencing for cancer liquid biopsy: advancing precision oncology - Scorecard - MDSpire

Long-read sequencing for cancer liquid biopsy: advancing precision oncology

  • By

  • Grace Guzman

  • Analiz Rodriguez

  • June 10, 2026

  • 0 min

Share

Clinical Scorecard: Utilizing Long-Read Sequencing in Liquid Biopsy for Enhanced Precision in Oncology

At a Glance

CategoryDetail
Condition
Key MechanismsLong-read sequencing (LRS) technologies enable detection of structural variants, haplotype phasing, fusion transcripts, and epigenetic modifications.
Target Population
Care Setting

Key Highlights

    Guideline-Based Recommendations

    Diagnosis

      Management

        Monitoring & Follow-up

          Risks

            Patient & Prescribing Data

            Clinical Best Practices

              Related Resources & Content

              Original Source(s)

              Long-read sequencing for cancer liquid biopsy: advancing precision oncology

              • by Grace Guzman, Analiz Rodriguez

              • June 10, 2026

              Related Content

              BCOR-CCNB3 fusion–positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up

              Clinical spectrum and treatment of thyroid lymphoma: results of a cohort study of 61 patients

              Multimodal treatment and long-term survival in a rare case of melanoma with pancreatic and splenic metastases: a case report and literature review